Baker Brothers Advisors - NEURODERM LTD ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of NEURODERM LTD
ValueSharesWeighting
Q3 2017$22,238,000
+30.1%
571,6670.0%0.18%
+20.8%
Q2 2017$17,093,000
+12.6%
571,6670.0%0.15%
+20.2%
Q1 2017$15,178,000
+19.6%
571,6670.0%0.12%0.0%
Q4 2016$12,691,000
+125.1%
571,667
+87.4%
0.12%
+143.1%
Q3 2016$5,639,000
+13.8%
305,0000.0%0.05%
-1.9%
Q2 2016$4,956,000
+15.1%
305,0000.0%0.05%
+15.6%
Q1 2016$4,307,000
-17.2%
305,0000.0%0.04%
+4.7%
Q4 2015$5,200,000
-17.5%
305,0000.0%0.04%
-25.9%
Q3 2015$6,304,000
+64.3%
305,000
+22.0%
0.06%
+70.6%
Q2 2015$3,838,000
+14.4%
250,0000.0%0.03%
+21.4%
Q1 2015$3,355,000
-4.4%
250,0000.0%0.03%
-22.2%
Q4 2014$3,510,000250,0000.04%
Other shareholders
NEURODERM LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 261,945$4,466,0003.96%
ACUTA CAPITAL PARTNERS, LLC 477,300$8,138,0003.89%
Avoro Capital Advisors LLC 520,022$8,866,0003.05%
Redmile Group, LLC 1,589,261$27,097,0002.03%
NEXTHERA CAPITAL LP 48,000$818,0001.16%
SCOPIA CAPITAL MANAGEMENT LP 2,749,038$46,871,0000.93%
SENZAR ASSET MANAGEMENT, LLC 201,700$3,438,985,0000.38%
Perceptive Advisors 270,000$4,604,0000.34%
Foresite Capital Management II, LLC 55,779$951,0000.32%
RA Capital Management 144,671$2,467,0000.24%
View complete list of NEURODERM LTD shareholders